TY - JOUR
T1 - Excess liver-related mortality among people with AIDS compared to the general population
T2 - an Italian nationwide cohort study using multiple causes of death
AU - Taborelli, M.
AU - Suligoi, B.
AU - Toffolutti, F.
AU - Frova, L.
AU - Grande, E.
AU - Grippo, F.
AU - Pappagallo, M.
AU - Pugliese, L.
AU - Regine, V.
AU - Serraino, D.
AU - Zucchetto, A.
N1 - Funding Information:
The authors thank Mrs L. Mei for editorial assistance and Mr. Stefano Boros for National AIDS Registry data management. Funding: None. Conflicts of interest: The authors have no conflicts of interest to declare.
Publisher Copyright:
© 2020 British HIV Association
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020/11/1
Y1 - 2020/11/1
N2 - Objectives: Liver diseases have become a leading cause of death among people with AIDS (PWA). This study aimed to investigate whether PWA experienced excess mortality related to liver diseases as compared to the general population (non-PWA), using a multiple cause of death (MCoD; i.e. all conditions reported on death certificates) approach. Methods: A population-based, nationwide, retrospective cohort study was conducted among Italian people, aged 15–74 years, who had been diagnosed with AIDS since 2006. Date of death and MCoD data were retrieved, up to December 2015, by individual record linkage with national mortality data. Sex- and age-standardized mortality ratios (SMRs), with 95% confidence intervals (CIs), were estimated by dividing the observed number of deaths related to a specific condition among PWA to the expected number, based on non-PWA mortality rates. Results: Among 7912 PWA (34 184 person-years), 2076 deaths occurred. The number of death certificates reporting liver diseases among MCoDs was 583 (28.1%), including 382 (18.4%) reporting viral hepatitis, 370 (17.8%) reporting nonviral liver diseases, and 41 (2.0%) reporting liver cancers. The corresponding SMRs were 40.4 (95% CI 37.2–43.8) for all liver diseases, 131.1 (95% CI 118.3–145.0) for viral hepatitis, 29.9 (95% CI 27.0–33.1) for nonviral liver diseases, and 11.2 (95% CI 8.1–15.3) for liver cancers. Particularly elevated SMRs emerged among PWA aged 15–49 years and those infected by injecting drug use. Conclusions: The high excess liver-related mortality observed among PWA warrants preventive actions to limit the burden of viral hepatitis coinfections, alcohol abuse, and metabolic disorders, especially among younger PWA and injecting drug users.
AB - Objectives: Liver diseases have become a leading cause of death among people with AIDS (PWA). This study aimed to investigate whether PWA experienced excess mortality related to liver diseases as compared to the general population (non-PWA), using a multiple cause of death (MCoD; i.e. all conditions reported on death certificates) approach. Methods: A population-based, nationwide, retrospective cohort study was conducted among Italian people, aged 15–74 years, who had been diagnosed with AIDS since 2006. Date of death and MCoD data were retrieved, up to December 2015, by individual record linkage with national mortality data. Sex- and age-standardized mortality ratios (SMRs), with 95% confidence intervals (CIs), were estimated by dividing the observed number of deaths related to a specific condition among PWA to the expected number, based on non-PWA mortality rates. Results: Among 7912 PWA (34 184 person-years), 2076 deaths occurred. The number of death certificates reporting liver diseases among MCoDs was 583 (28.1%), including 382 (18.4%) reporting viral hepatitis, 370 (17.8%) reporting nonviral liver diseases, and 41 (2.0%) reporting liver cancers. The corresponding SMRs were 40.4 (95% CI 37.2–43.8) for all liver diseases, 131.1 (95% CI 118.3–145.0) for viral hepatitis, 29.9 (95% CI 27.0–33.1) for nonviral liver diseases, and 11.2 (95% CI 8.1–15.3) for liver cancers. Particularly elevated SMRs emerged among PWA aged 15–49 years and those infected by injecting drug use. Conclusions: The high excess liver-related mortality observed among PWA warrants preventive actions to limit the burden of viral hepatitis coinfections, alcohol abuse, and metabolic disorders, especially among younger PWA and injecting drug users.
KW - AIDS
KW - hepatic diseases
KW - HIV
KW - liver
KW - liver cancer
KW - multiple cause of death
KW - standardized mortality ratio
UR - http://www.scopus.com/inward/record.url?scp=85090083076&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85090083076&partnerID=8YFLogxK
U2 - 10.1111/hiv.12937
DO - 10.1111/hiv.12937
M3 - Article
C2 - 32876382
AN - SCOPUS:85090083076
VL - 21
SP - 642
EP - 649
JO - HIV Medicine
JF - HIV Medicine
SN - 1464-2662
IS - 10
ER -